|
|
|
|
|
|
Sponsors and Collaborators: |
Dana-Farber Cancer Institute Brigham and Women's Hospital |
Information provided by: | Dana-Farber Cancer Institute |
ClinicalTrials.gov Identifier: | NCT00165126 |
The purpose of this study is to investigate the effect of certain variables such as the fullness of the patients bladder and the position of the treatment applicator on the dose of radiation that other organs such as the bladder and the rectum receive during radiation treatment for endometrial carcinoma.
Condition | Intervention |
Endometrial Carcinoma Cervix Cancer Carcinoma of the Uterus |
Procedure: Radiation therapy |
MedlinePlus related topics: | Cancer Cervical Cancer |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Dosimetric Analysis of Vaginal Cuff Brachytherapy in Endometrial Carcinoma |
Enrollment: | 40 |
Study Start Date: | January 2004 |
Estimated Study Completion Date: | January 2008 |
Primary Completion Date: | January 2006 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 18 Years to 90 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Patients with carcinoma of the uterus, post-hysterectomy stages I-IVA or vaginal cuff recurrence or post-hysterectomy cervix cancer stages IA or IB or post hysterectomy vaginal cancer stage I that will be undergoing radiation therapy.
Inclusion Criteria:
Exclusion Criteria:
United States, Massachusetts | |||||
Dana-Farber Cancer Institute | |||||
Boston, Massachusetts, United States, 02115 | |||||
Brigham and Women's Hospital | |||||
Boston, Massachusetts, United States, 02115 |
Dana-Farber Cancer Institute |
Brigham and Women's Hospital |
Principal Investigator: | Akila Viswanathan, MD, MPH | Dana-Farber Cancer Institute/Brigham and Women's Hospital |
Responsible Party: | Dana-Farber Cancer Institute ( Akila Viswanathan, MD ) |
Study ID Numbers: | 03-315 |
First Received: | September 9, 2005 |
Last Updated: | December 20, 2007 |
ClinicalTrials.gov Identifier: | NCT00165126 |
Health Authority: | United States: Institutional Review Board |
|
|
|
|